Molecular Medicine

, Volume 9, Issue 3–4, pp 77–84 | Cite as

Requirement of STAT3 Activation for Differentiation of Mucosal Stratified Squamous Epithelium

  • Rong Wu
  • Shishinn Sun
  • Bettie M Steinberg


STAT3, a member of the signal transducers and activators of transcription (STAT) family, has been shown to play a key role in promoting proliferation, differentiation, or cell cycle progression, depending on cell type. A number of signaling pathways are altered in laryngeal papillomas, benign tumors induced by human papillomavirus 6/11. Papillomas overexpress the epidermal growth factor receptor and display enhanced MAP kinase and PI-3-kinase activity. They also show reduced activation of Akt and reduced levels of tyrosine-phosphorylated STAT3, due to overexpression of the tumor suppressor, PTEN. As papillomas show abnormalities in terminal differentiation, we examined the potential role of STAT3 in regulating epithelial differentiation. Laryngeal epithelial cells were suspended in supplemented serum-free medium. Differentiation was measured by Western blot analysis of keratin 13. Normal laryngeal epithelial cells were transfected with a constitutively active STAT3 or a dominant negative STAT3. Cells were transferred to suspension culture 24 h after transfection. Increased expression of keratin 13 was accompanied by the activation of STAT3 when differentiation was induced, and expression of a constitutively active STAT3 (STAT3C) enhanced the expression of keratin 13. In contrast, expression of a dominant negative STAT3 (Y705F) inhibited the expression of keratin 13. We conclude that activation of STAT3 is required for the differentiation of normal human stratified squamous epithelium.



This work was supported by grant P50DC00203 from the National Institute on Deafness and Other Communication Disorders and a Faculty Research Award from the North Shore-Long Island Jewish Research Institute.

We thank Dr Jennifer Grandis and Dr James Darnell who provided the dominant-negative STAT3 and the constitutively active STAT3. We express our gratitude to Dr Danile Besser who provided the STAT3 luciferase reporter and control constructs. Also, we thank Dr Allan Abramson and Dr Mark Shikowitz who provided normal and papilloma tissues, and May Nouri who provided normal laryngeal cell cultures.


  1. 1.
    Gissman L, Diehl B, Schults-Coulon J, zur Hausen H. (1982) Molecular cloning and characterization of human papillomavirus DNA derived from a laryngeal papilloma. J. Virol. 44:393–9.Google Scholar
  2. 2.
    Abramson AL, Steinberg BM, Winkler B. (1987) Laryngeal papillomatosis: clinical, histopathologic and molecular studies. Laryngoscope. 97:678–85.CrossRefGoogle Scholar
  3. 3.
    Steinberg BM, Meade R, Kalinowski S, Abramson AL. (1990) Abnormal differentiation of human papillomavirus-induced laryngeal papillomas. Arch. Otolaryngol. Head Neck Surg. 116:1167–71.CrossRefGoogle Scholar
  4. 4.
    Fuchs E, Green H. (1980) Changes in keratin gene expression during terminal differentiation of the keratinocyte. Cell. 19:1033–42.CrossRefGoogle Scholar
  5. 5.
    Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. (1982) The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell. 31:11–24.CrossRefGoogle Scholar
  6. 6.
    Sun TT, Eichner R, Schermer A, Cooper D, Nelson WG, Weiss R.A. (1984) Classification, expression, and possible mechanisms of evolution of mammalian epithelial keratins: a unifying model. In: Cancer cells/1. The transformed phenotype. Levine AJ et al (ed.). N.Y.: Cold Spring Harbor Laboratory Press. p 169–76.Google Scholar
  7. 7.
    Fuchs E. (1993) Epidermal differentiation and keratin gene expression. J. Cell Sci. Suppl. 17:197–208.CrossRefGoogle Scholar
  8. 8.
    Johnston D, Hall H, DiLorenzo TP, Steinberg BM. (1999) Elevation of the epidermal growth factor receptor and dependent signaling in human papillomavirusinfected laryngeal papillomas. Cancer Res. 59:968–74.PubMedGoogle Scholar
  9. 9.
    Vambutas A, Di Lorenzo TP, Steinberg BM. (1993) Laryngeal papilloma cells have high levels of epidermal growth factor receptor and respond to epidermal growth factor by a decrease in epithelial differentiation. Cancer Res. 53:910–4.PubMedGoogle Scholar
  10. 10.
    Zhang P, Steinberg BM. (2000) Overexpression of PTEN/MMAC1 and decreased activation of Akt in human papillomavirus-infected laryngeal papillomas. Cancer Res. 60:1457–62.PubMedGoogle Scholar
  11. 11.
    Sun S, Steinberg BM. (2002) PTEN is a negative regulator of STAT3 activation in human papillomavirus-infected cells. J. Gen. Virol. 83:1651–8.CrossRefGoogle Scholar
  12. 12.
    Minami M, Inoue M, Wei S, Takeda K, Matsumoto M, Kishimoto T, Akira S. (1996) STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line. Proc. Natl. Acad. Sci. U.S.A. 93:3963–6.CrossRefGoogle Scholar
  13. 13.
    McLemore ML, Grewal S, Liu F, Archambault A, Poursine-Laurent J, Haug J, Link DC. (2001) STAT-3 activation is required for normal G-CSF-dependent proliferation and granulocytic differentiation. Immunity. 14:193–204.CrossRefGoogle Scholar
  14. 14.
    de Koning JP, Ward AC, Caldenhoven E, de Groot RP, Lowenberg, B, Touw IP. (2000) STAT3beta does not interfere with granulocyte colony-stimulating factor-induced neutrophilic differentiation. Hematol. J. 1:220–5.CrossRefGoogle Scholar
  15. 15.
    Danial NN, Pernis A, Rothman PB. (1995) Jak-STAT signaling induced by the v-abl oncogene. Science. 269:1875–7.CrossRefGoogle Scholar
  16. 16.
    David M, Wong L, Flavell R, Thompson SA, Wells A, Larner AC, Johnson GR. (1996) STAT activation by epidermal growth factor (EGF) and amphiregulin. Requirement for the EGF receptor kinase but not for tyrosine phosphorylation sites or JAK1. J. Biol. Chem. 271:9185–8.CrossRefGoogle Scholar
  17. 17.
    Park OK, Schaefer TS, Nathans D. (1996) In vitro activation of Stat3 by epidermal growth factor receptor kinase. Proc. Natl. Acad. Sci. U.S.A. 93:13704–8.CrossRefGoogle Scholar
  18. 18.
    Yu CL, Meyer DJ, Campbell GS, Larner AC, Carter-Su C, Schwartz J, Jove R. (1995) Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science. 269:81–3.CrossRefGoogle Scholar
  19. 19.
    Darnell Jr JE. (1997) STATs and gene regulation. Science. 277:1630–5.CrossRefGoogle Scholar
  20. 20.
    Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C, Darnell Jr JE. (1999) Stat3 as an oncogene. Cell. 98:295–303.CrossRefGoogle Scholar
  21. 21.
    Grandis JR, Drenning SD, Chakraborty A, Zhou MY, Zeng Q, Pitt AS, Tweardy DJ. (1998) Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor-mediated cell growth in vitro. J. Clin. Invest. 102:1385–92.CrossRefGoogle Scholar
  22. 22.
    Zhong Z, Wen Z, Darnell Jr JE. (1994) Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science. 264:95–8.CrossRefGoogle Scholar
  23. 23.
    Nakajima K, Yamanaka Y, Nakae K, Kojima H, Ichiba M, Kiuchi N, Kitaoka T, Fukada T, Hibi M, Hirano T. (1996) A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells. Embo. J. 15:3651–8.CrossRefGoogle Scholar
  24. 24.
    Yamanaka Y, Nakajima K, Fukada T, Hibi M, Hirano T. (1996) Differentiation and growth arrest signals are generated through the cytoplasmic region of gp130 that is essential for Stat3 activation. Embo. J. 15:1557–65.CrossRefGoogle Scholar
  25. 25.
    Zhang J, Shen B, Li Y, Sun Y. 2001 STAT3 exerts two-way regulation in the biological effects of IL-6 in M1 leukemia cells. Leuk. Res. 25:463–72.CrossRefGoogle Scholar
  26. 26.
    Rane SG, Reddy EP. (1994) JAK3: a novel JAK kinase associated with terminal differentiation of hematopoietic cells. Oncogene 9:2415–23.PubMedGoogle Scholar
  27. 27.
    Runge D, Runge DM, Drenning SD, Bowen Jr WC, Grandis JR, Michalopoulos GK. (1998) Growth and differentiation of rat hepatocytes: changes in transcription factors HNF-3, HNF-4, STAT-3, and STAT-5. Biochem. Biophys. Res. Commun. 250:762–8.CrossRefGoogle Scholar
  28. 28.
    Smithgall TE, Briggs SD, Schreiner S, Lerner EC, Cheng H, Wilson MB. (2000) Control of myeloid differentiation and survival by Stats. Oncogene. 19:2612–8.CrossRefGoogle Scholar
  29. 29.
    Ward AC, Touw I, Yoshimura A. (2000) The Jak-Stat pathway in normal and perturbed hematopoiesis. Blood. 95:19–29.PubMedGoogle Scholar
  30. 30.
    Steinberg BM, Abramson AL, Meade RP. (1982) Culture of human laryngeal papilloma cells in vitro. Otolaryngol. Head Neck Surg. 90:728–35.CrossRefGoogle Scholar
  31. 31.
    Green H, Kehinde O, Thomas J. (1979) Growth of cultured human epidermal cells into multiple epithelia suitable for grafting. Proc. Natl. Acad. Sci. U.S.A. 76:5665–8.CrossRefGoogle Scholar
  32. 32.
    Wakita H, Takigawa M. (1999) Activation of epidermal growth factor receptor promotes late terminal differentiation of cell-matrix interaction-disrupted keratinocytes. J. Biol. Chem. 274:37285–91.CrossRefGoogle Scholar
  33. 33.
    Stasiak PC, Purkis PE, Leigh IM, Lane EB. (1989) Keratin 19: predicted amino acid sequence and broad tissue distribution suggest it evolved from keratinocyte keratins. J. Invest. Dermatol. 92:707–16.CrossRefGoogle Scholar
  34. 34.
    Forde AM, Feighery C, Jackson J. (1998) Characterisation of anti-neutrophil cytoplasmic antibody target antigens using electrophoresis and western blotting techniques. Br. J. Biomed. Sci. 55:247–52.PubMedGoogle Scholar
  35. 35.
    Eichner R, Bonitz P, Sun TT. (1984) Classification of epidermal keratins according to their immunoreactivity, isoelectric point, and mode of expression. J. Cell Biol. 98:1388–96.CrossRefGoogle Scholar
  36. 36.
    Grandis JR, Zeng Q, Drenning SD. (2000) Epidermal growth factor receptor— mediated stat3 signaling blocks apoptosis in head and neck cancer. Laryngoscope. 110:868–74.CrossRefGoogle Scholar
  37. 37.
    Besser D, Bromberg JF, Darnell Jr JE, Hanafusa H. (1999) A single amino acid substitution in the v-Eyk intracellular domain results in activation of Stat3 and enhances cellular transformation. Mol. Cell Biol. 19:1401–9.CrossRefGoogle Scholar
  38. 38.
    Hsu SM, Raine L, Fanger H. (1981) The use of antiavidin antibody and avidinbiotin-peroxidase complex in immunoperoxidase technics. Am. J. Clin. Pathol. 75:816–21.CrossRefGoogle Scholar
  39. 39.
    Shimozaki K, Nakajima K, Hirano T, Nagata S. (1997) Involvement of STAT3 in the granulocyte colony-stimulating factor-induced differentiation of myeloid cells. J. Biol. Chem. 272:25184–9.CrossRefGoogle Scholar
  40. 40.
    Frisch SM, Francis H. (1994) Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 124:619–26.CrossRefGoogle Scholar
  41. 41.
    Hauser PJ, Agrawal D, Hackney J, Pledger WJ. (1998) STAT3 activation accompanies keratinocyte differentiation. Cell Growth Differ. 9:847–55.PubMedGoogle Scholar
  42. 42.
    Andersen B, Weinberg WC, Rennekampff O, McEvilly RJ, Bermingham Jr JR, Hooshmand F, Vasilyev V, Hansbrough JF, Pittelkow MR, Yuspa SH, Rosenfeld MG. (1997) Functions of the POU domain genes Skn-1a/i and Tst-1/Oct-6/SCIP in epidermal differentiation. Genes Dev. 11:1873–84.CrossRefGoogle Scholar
  43. 43.
    Faus I, Hsu HJ, Fuchs E. (1994) Oct-6: a regulator of keratinocyte gene expression in stratified squamous epithelia. Mol. Cell Biol. 14:3263–75.CrossRefGoogle Scholar
  44. 44.
    Chen TT, Wu RL, Castro-Munozledo F, Sun TT. (1997) Regulation of K3 keratin gene transcription by Sp1 and AP-2 in differentiating rabbit corneal epithelial cells. Mol. Cell Biol. 17:3056–64.CrossRefGoogle Scholar
  45. 45.
    Wanner R, Zhang J, Henz BM, Rosenbach T. (1996) AP-2 gene expression and modulation by retinoic acid during keratinocyte differentiation, Biochem. Biophys. Res. Commun. 223:666–9.CrossRefGoogle Scholar
  46. 46.
    Waseem A, Alam Y, Dogan B, White KN, Leigh IM, Waseem NH. (1998) Isolation, sequence and expression of the gene encoding human keratin 13. Gene. 215:269–79.CrossRefGoogle Scholar
  47. 47.
    Demeterco C, Itkin-Ansari P, Tyrberg B, Ford LP, Jarvis RA, Levine F. (2002) c-Myc controls proliferation versus differentiation in human pancreatic endocrine cells. J. Clin. Endocrinol. Metab. 87:3475–85.CrossRefGoogle Scholar
  48. 48.
    Gorelik L, Constant S, Flavell RA. (2002) Mechanism of transforming growth factor beta-induced inhibition of T helper type 1 differentiation. J. Exp. Med. 195:1499–505.CrossRefGoogle Scholar

Copyright information

© Feinstein Institute for Medical Research 2003

Authors and Affiliations

  1. 1.North Shore-Long Island Jewish Research Institute and Department of Otolaryngology and Communicative DisordersLong Island Jewish Medical CenterNew YorkUSA

Personalised recommendations